- Home
- CLGN vs CNF Comparison
CLGN vs CNF Comparison
Compare CLGN & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- CNF
- Stock Information
- Founded
- CLGN 2004
- CNF 1999
- Country
- CLGN Israel
- CNF China
- Employees
- CLGN N/A
- CNF N/A
- Industry
- CLGN Industrial Specialties
- CNF Finance: Consumer Services
- Sector
- CLGN Health Care
- CNF Finance
- Exchange
- CLGN Nasdaq
- CNF Nasdaq
- Market Cap
- CLGN 22.1M
- CNF 36.9M
- IPO Year
- CLGN N/A
- CNF 2018
- Fundamental
- Price
- CLGN $2.28
- CNF $0.43
- Analyst Decision
- CLGN Strong Buy
- CNF
- Analyst Count
- CLGN 2
- CNF 0
- Target Price
- CLGN $11.50
- CNF N/A
- AVG Volume (30 Days)
- CLGN 173.3K
- CNF 125.1K
- Earning Date
- CLGN 05-28-2025
- CNF 04-30-2025
- Dividend Yield
- CLGN N/A
- CNF N/A
- EPS Growth
- CLGN N/A
- CNF N/A
- EPS
- CLGN N/A
- CNF 0.08
- Revenue
- CLGN $2,472,000.00
- CNF $85,661,735.00
- Revenue This Year
- CLGN $2,177.67
- CNF $252.34
- Revenue Next Year
- CLGN $56.52
- CNF N/A
- P/E Ratio
- CLGN N/A
- CNF $5.32
- Revenue Growth
- CLGN N/A
- CNF N/A
- 52 Week Low
- CLGN $1.55
- CNF $0.37
- 52 Week High
- CLGN $5.60
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- CLGN 49.21
- CNF 27.49
- Support Level
- CLGN $1.90
- CNF $0.65
- Resistance Level
- CLGN $4.98
- CNF $0.75
- Average True Range (ATR)
- CLGN 0.45
- CNF 0.06
- MACD
- CLGN 0.16
- CNF -0.02
- Stochastic Oscillator
- CLGN 21.28
- CNF 15.84
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.